Evidence map›Paper›PMID 38931821›Full record

ArticlePharmaceutics2024

Formulation of a Novel Hesperetin-Loaded Nanoemulsion and Its Promising Effect on Osteogenesis.

Maria Júlia Mancim-Imbriani, Jonatas Lobato Duarte, Leonardo Delello Di Filippo, Letícia Pereira Lima Durão, Marlus Chorilli, Denise Madalena Palomari Spolidorio, Patricia Milagros Maquera-Huacho

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Hesperetin mitigates IBD-associated bone loss viaJournal of orthopaedic translation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maria Júlia Mancim-ImbrianiDepartment of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.ORCID 0000-0002-3600-0307
Jonatas Lobato DuarteDepartment of Drugs and Medicines, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara CEP 14800-903, São Paulo, Brazil.ORCID 0000-0002-7276-3686
Leonardo Delello Di FilippoDepartment of Drugs and Medicines, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara CEP 14800-903, São Paulo, Brazil.ORCID 0000-0001-6365-8756
Letícia Pereira Lima DurãoDepartment of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.
Marlus ChorilliDepartment of Drugs and Medicines, São Paulo State University (UNESP), School of Pharmaceutical Sciences, Araraquara CEP 14800-903, São Paulo, Brazil.ORCID 0000-0002-6698-0545
Denise Madalena Palomari SpolidorioDepartment of Physiology and Pathology, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.
Patricia Milagros Maquera-HuachoDepartment of Diagnosis and Surgery, São Paulo State University (UNESP), School of Dentistry, Araraquara CEP 14801-385, São Paulo, Brazil.ORCID 0000-0002-2193-9979

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/16540-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/14155-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/05881-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/15178-6
6 · The paper itself

Abstract

Alternative therapies associating natural products and nanobiotechnology show new perspectives on controlled drug release. In this context, nanoemulsions (NEs) present promising results for their structural design and properties. Hesperetin (HT), a flavonoid mainly found in citrus fruits, presents highlighted bone benefits. In this context, we developed a hesperetin-loaded nanoemulsion (HT-NE) by sonication method and characterized it by dynamic light scattering, analyzing its encapsulation efficiency, and cumulative release. The biocompatibility in human osteoblasts Saos-2-like was evaluated by the cytotoxicity assay and IC

Indexed as

bone regenerationcytotoxicity testsflavonoidshesperetinmaterials testingnanoparticles

Identifiers

PMID38931821
PMCPMC11206411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.